The main purpose of this legislation, known as the "Advancing Safe Medications for Moms and Babies Act of 2026," is to improve the inclusion of pregnant and lactating women in clinical research. The goal is to ensure that medical studies account for the health needs of these women and their infants, ultimately leading to safer medications and better health outcomes. Key provisions of the legislation include several important actions.